[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341038-105":59,"doc-detail-341038-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","comparative-study-between-poorly-differentiated-thyroid-cancer-and-anaplastic-thyroid-cancer-real-world-pathological-distribution-death-attribution-and-prognostic-factor-estimation","Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer - real-world pathological distribution, death attribution, and prognostic factor estimation","","Clinic-pathological boundaries between poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) remain uncertain because of broad histopathologic variability and the rarity of ATC. Using a SEER cohort of 4,947 PDTC/ATC patients from 2000–2018, survival was estimated with Kaplan–Meier methods and prognostic relationships assessed by Cox proportional hazards regression. Real-world death attribution quantified thyroid- versus non-thyroid causes and identified independent adverse predictors for outcomes.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comparative-study-between-poorly-differentiated-thyroid-cancer-and-anaplastic-thyroid-cancer-real-world-pathological-distribution-death-attribution-and-prognostic-factor-estimation/341038/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comparative-study-between-poorly-differentiated-thyroid-cancer-and-anaplastic-thyroid-cancer-real-world-pathological-distribution-death-attribution-and-prognostic-factor-estimation/341038.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"How were patients selected for the study?","Question",{"text":113,"@type":114},"A total of 4,947 PDTC/ATC patients from 2000 to 2018 were identified from the Surveillance, Epidemiology, and End Results (SEER) database.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which statistical methods were used to evaluate survival and prognosis?",{"text":118,"@type":114},"Kaplan–Meier survival curve estimation and Cox proportional hazard regression were applied.",{"name":120,"@type":111,"acceptedAnswer":121},"What did death attribution analysis show during follow-up?",{"text":122,"@type":114},"During follow-up, 68.1% of the cohort were dead; 51.6% of deaths were attributed to thyroid malignancies and 16.5% to non-thyroid causes.",{"name":124,"@type":111,"acceptedAnswer":125},"What factors were identified as independent predictors of worse outcomes?",{"text":126,"@type":114},"Older age with unidentifiable histology, more advanced AJCC N1b and AJCC M1 stages, higher SEER stage, tumor size >5 cm, and more invasive tumor extension were independent adverse predictors.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},341038,1790578678,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Original Research PUBLISHED 13 March 2024  \nDOI 10.3389/fendo.2024.1347362  \nOPEN ACCESS  \nEDITED BY  \nCristina Alina Silaghi,  \nUniversity of Medicine and Pharmacy Iuliu Hatieganu, Romania  \nREVIEWED BY  \nCostanza Chiapponi,  \nUniversity Hospital of Cologne, Germany Barbara Maria Jarzab,  \nMaria Skłodowska-Curie National Research Institute of Oncology, Poland  \n*CORRESPONDENCE Ya-Wen Chen  \n[yawen.chen@mssm.edu](yawen.chen@mssm.edu)[ ](yawen.chen@mssm.edu)Kun Zhang  \n [zhangkun5616@wchscu.edu.cn](zhangkun5616@wchscu.edu.cn)  \nRECEIVED 30 November 2023  \nACCEPTED 26 February 2024  \nPUBLISHED 13 March 2024  \nCITATION  \nZhang K, Wang X, Wei T, Li Z, Zhu J and Chen Y-W (2024) Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation.  \nFront. Endocrinol. 15:1347362 .  \ndoi: 10.3389/fendo.2024.1347362  \nCOPYRIGHT  \n© 2024 Zhang, Wang, Wei, Li, Zhu and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nComparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation  \nKun Zhang 1*, Xinyi Wang 1, Tao Wei 1, Zhihui Li 1, Jingqiang Zhu 1 and Ya-Wen Chen 2,3,4,5,6*  \n1 Division of Thyroid Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China, 2 Department of Otolaryngology, Icahn School of Medicine at Mount Sinai, New York, NY, United States, 3 Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY, United States, 4 Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States, 5 Institute for Airway Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States, 6Center for Epithelial and Airway Biology and Regeneration, Icahn School of Medicine at Mount Sinai, New York, NY, United States  \nBackground: The clinic-pathological boundary between poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) is unclear due to a wide spectrum of histopathological features and the rarity of the disease. In addition to that, with the highest mortality rate and non-standard treatment modality, the PDTC/ATC population has not been subjected to comprehensive description and comparison with the extent of histological characteristics, therapeutic response, prognostic factors, and death attribution analysis.  \nMethod: A total of 4,947 PDTC/ATC patients from 2000 to 2018 were identiﬁed from the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan– Meier survival curve estimation and Cox proportional hazard regression were applied.  \nResults: Overall, the 5-and 10-year DSS for PDTC were 71 . 9% and 68 . 0%, respectively, whereas the 5-and 10-year OS are 59 .3% and 51 . 2%, respectively. The median survival time for ATC patients was 3 months with 1-year OS being 26. 9% and 1-year DSS being 31 . 2% . During the follow-up period, 68 . 1% of the PDTC/ATC cohort were dead, 51.6% of which were attributed to thyroid malignancies and 16 . 5% to non-thyroid causes. The top three common nonthyroid causes of death were miscellaneous cancers, lower respiratory system disease, and heart disease. The histological feature of papillary thyroid cancer (PTC) was the leading pathological category for PDTC patients (51.7%), whereas 76.7% of ATC patients’ pathological feature was characterized as unidentiﬁable. Sarcoma histologica","cbCaiu2cvyacDdXY","https://ap.wps.com/l/cbCaiu2cvyacDdXY","pdf",1396699,13,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"How were patients selected for the study?\",\"answer\":\"A total of 4,947 PDTC/ATC patients from 2000 to 2018 were identified from the Surveillance, Epidemiology, and End Results (SEER) database.\"},{\"question\":\"Which statistical methods were used to evaluate survival and prognosis?\",\"answer\":\"Kaplan–Meier survival curve estimation and Cox proportional hazard regression were applied.\"},{\"question\":\"What did death attribution analysis show during follow-up?\",\"answer\":\"During follow-up, 68.1% of the cohort were dead; 51.6% of deaths were attributed to thyroid malignancies and 16.5% to non-thyroid causes.\"},{\"question\":\"What factors were identified as independent predictors of worse outcomes?\",\"answer\":\"Older age with unidentifiable histology, more advanced AJCC N1b and AJCC M1 stages, higher SEER stage, tumor size \\u003e5 cm, and more invasive tumor extension were independent adverse predictors.\"}]","Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer - real-world pathological distribution, death attribution, and prognostic factor estimation | PDF",1790040057,33,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d08ab5f04cd29f150da35849ddfd8ae.webp",983,1389,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/953e056a55ec54f9c9fd9dbf0cb04cab.webp",982,1388,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f5dfe162010f4ba30c8be267e857301.webp",981,1386,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6aeea7882fb08292b1570ac21588dbe1.webp",980,1385]